Home » Topics » Regulatory

Regulatory
RSS

Important end-of-year approval by FDA: Celebrex for arthritis

Jan. 4, 1999

Expanded use of Photofrin approved by FDA

Jan. 4, 1999

Prometrium cleared for U.S. marketing for HRT

Jan. 4, 1999

New indications for Prograf scheduled for FDA advisory committee review

Dec. 30, 1998

Miltefosine evaluated clinically for the oral treatment of visceral leishmaniasis

Dec. 22, 1998

FDA approves first Lyme disease vaccine

Dec. 22, 1998

FDA approves abacavir for treatment of HIV-1 infection

Dec. 21, 1998

Expanded indications, new formulation of Lamictal now available in U.S.

Dec. 21, 1998

Chirocaine receives first regulatory approval in Sweden

Dec. 18, 1998

Orphan Medical files NDS for Busulfex Injection in Canada

Dec. 17, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...